Login / Signup

Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial.

Ying ZhaoYuan-Yuan YangBao-Lin YangYa-Wei DuDa-Wei RenHong-Mei ZhouJing WangHui-Min YangYao-Xian WangYing-Ying ZhangSheng-Xian Wu
Published in: Trials (2021)
Chinese Clinical Trial Registry ChiCTR1900021361 . Registered on 17 February 2019.
Keyphrases
  • double blind
  • clinical trial
  • placebo controlled
  • phase ii
  • phase iii
  • study protocol